Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1993 1
1995 1
1996 2
1997 1
1998 2
1999 3
2000 1
2006 3
2007 3
2008 3
2009 8
2010 7
2011 5
2012 11
2013 7
2014 8
2015 10
2016 6
2017 3
2018 4
2019 6
2020 8
2021 11
2022 12
2023 6
2024 1
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
Diabetes Prevention Program Research Group; Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. Diabetes Prevention Program Research Group, et al. Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29. Lancet. 2009. PMID: 19878986 Free PMC article. Clinical Trial.
Effective CAR T-cell targeting of an MUC1 cleavage product.
Smagghe BJ, Carter MG, Yi KR, Nash JSS, Grant TJ, Miller DS, Moe ST, Smith DD, Nash MJ, Miller NK, Agarkov LL, Marquez JP, Stewart AK, Bamdad CC. Smagghe BJ, et al. J Immunother Cancer. 2025 May 30;13(5):e010577. doi: 10.1136/jitc-2024-010577. J Immunother Cancer. 2025. PMID: 40447312 Free PMC article.
BACKGROUND: We developed Chimeric antigen receptor (CAR) T cells targeting mucin 1 (MUC1)* (muk * (muk 1 star)), which is the tumor-associated growth factor receptor form of MUC1. ...Post-sacrifice analysis showed that the CAR T cells with 1XX mutations persisted lo …
BACKGROUND: We developed Chimeric antigen receptor (CAR) T cells targeting mucin 1 (MUC1)* (muk * (muk 1 star)), which is the tumor-a …
Effect of Opium Versus Methadone on Polysomnographic Characteristics of Patients With Obesity Hypoventilation Syndrome.
Amra B, Narimani H, Soltaninejad F, Salmasi M, Mansourian M, Penzel T, Schöbel C, Fietze I. Amra B, et al. Basic Clin Neurosci. 2024 Jan-Feb;15(1):101-108. doi: 10.32598/bcn.2022.3901.1. Epub 2024 Jan 1. Basic Clin Neurosci. 2024. PMID: 39291091 Free PMC article.
METHODS: In this cross-sectional study, we enrolled 75 patients with OHS in the Bamdad Respiratory and Sleep Research Center affiliated with the Isfahan University of Medical Sciences between January 2020 and February 2021. ...Central apnea index (P=0.01), longest hypopnea …
METHODS: In this cross-sectional study, we enrolled 75 patients with OHS in the Bamdad Respiratory and Sleep Research Center affiliat …
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Li JH, Brenner LN, Kaur V, Figueroa K, Schroeder P, Huerta-Chagoya A; MAGIC Investigators; Diabetes Prevention Program (DPP) Research Group; Udler MS, Leong A, Mercader JM, Florez JC. Li JH, et al. Diabetologia. 2023 Jul;66(7):1260-1272. doi: 10.1007/s00125-023-05922-7. Epub 2023 May 26. Diabetologia. 2023. PMID: 37233759 Free PMC article.
Oriented, active Escherichia coli RNA polymerase: an atomic force microscope study.
Thomson NH, Smith BL, Almqvist N, Schmitt L, Kashlev M, Kool ET, Hansma PK. Thomson NH, et al. Biophys J. 1999 Feb;76(2):1024-33. doi: 10.1016/S0006-3495(99)77267-X. Biophys J. 1999. PMID: 9916034 Free PMC article.
Combining a system for binding proteins to surfaces (Sigal, G. B., C. Bamdad, A. Barberis, J. Strominger, and G. M. Whitesides. 1996. Anal. Chem. 68:490-497) with a method for making ultraflat gold surfaces (Hegner, M., P. ...
Combining a system for binding proteins to surfaces (Sigal, G. B., C. Bamdad, A. Barberis, J. Strominger, and G. M. Whitesides. 1996. …
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.
Georas SN, Wright RJ, Ivanova A, Israel E, LaVange LM, Akuthota P, Carr TF, Denlinger LC, Fajt ML, Kumar R, O'Neal WK, Phipatanakul W, Szefler SJ, Aronica MA, Bacharier LB, Burbank AJ, Castro M, Crotty Alexander L, Bamdad J, Cardet JC, Comhair SAA, Covar RA, DiMango EA, Erwin K, Erzurum SC, Fahy JV, Gaffin JM, Gaston B, Gerald LB, Hoffman EA, Holguin F, Jackson DJ, James J, Jarjour NN, Kenyon NJ, Khatri S, Kirwan JP, Kraft M, Krishnan JA, Liu AH, Liu MC, Marquis MA, Martinez F, Mey J, Moore WC, Moy JN, Ortega VE, Peden DB, Pennington E, Peters MC, Ross K, Sanchez M, Smith LJ, Sorkness RL, Wechsler ME, Wenzel SE, White SR, Zein J, Zeki AA, Noel P; PrecISE Study Team. Georas SN, et al. J Allergy Clin Immunol. 2022 Feb;149(2):488-516.e9. doi: 10.1016/j.jaci.2021.10.035. Epub 2021 Nov 29. J Allergy Clin Immunol. 2022. PMID: 34848210 Free PMC article. Review.
PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.
Denlinger LC, Israel E, Moore WC, Georas SN, Wright RJ, Castro M, Peden DB, Anstrom KJ, Bleecker ER, Alexander LC, Cahill KN, Cardet JC, Carr TF, Cedano J, Chen AY, Chupp GL, Comhair SAA, DiMango EA, Erzurum SC, Fahy JV, Fajt ML, Gaston BM, Jackson DJ, Jain S, Jarjour NN, Kenyon NJ, Kraft M, Krishnan JA, Kumar R, Lugogo NL, Martinez FD, Marquis MA, Pappalardo AA, Phipatanakul W, Rank MA, Rosenberg SR, Salciccioli JD, Sanchez M, Smith LJ, Sumino K, Szefler SJ, Tang M, Vijayanand P, Wechsler ME, Wenzel SE, White SR, Zeki AA, Ivanova A, Bacharier LB, Akuthota P; NHLBI PrecISE Study Team. Denlinger LC, et al. J Allergy Clin Immunol. 2026 Jun;157(6):1261-1273. doi: 10.1016/j.jaci.2026.02.001. Epub 2026 Feb 16. J Allergy Clin Immunol. 2026. PMID: 41707916 Clinical Trial.
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.
Yari A, Hosseini SY, Asiyabi S, Hajiahmadi N, Farahmand M, Bamdad T. Yari A, et al. Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12. Immunotherapy. 2025. PMID: 40353308 Free PMC article.
Tumor size, histopathological examination, CD8 and FOXP3 expression, the cytotoxicity of spleen T cell lymphocytes, and the secretion of Interferon-gamma (IFN-gamma) and Tumor necrosis factor- alpha (TNF-alpha) were examined. ...CEA is significant in cancer progression and …
Tumor size, histopathological examination, CD8 and FOXP3 expression, the cytotoxicity of spleen T cell lymphocytes, and the secretion …
Hepatitis C virus alternative reading frame protein (ARFP): Production, features, and pathogenesis.
Mohamadi M, Azarbayjani K, Mozhgani SH, Bamdad T, Alamdary A, Nikoo HR, Hashempour T, Hedayat Yaghoobi M, Ajorloo M. Mohamadi M, et al. J Med Virol. 2020 Dec;92(12):2930-2937. doi: 10.1002/jmv.26091. Epub 2020 Jun 12. J Med Virol. 2020. PMID: 32470157 Review.
The increment of CD4+, CD25+, and FoxP3+ T cells, along with CD8+ T cells with low expression of granzyme B, also leads to weaker responses of the immune system which helps the infection to become chronic. ...
The increment of CD4+, CD25+, and FoxP3+ T cells, along with CD8+ T cells with low expression of granzyme B, also leads to wea …
F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.
Hashempour T, Bamdad T, Bergamini A, Lavergne JP, Haj-Sheykholeslami A, Brakier-Gingras L, Ajorloo M, Merat S. Hashempour T, et al. Pathog Dis. 2015 Jun;73(4):ftv022. doi: 10.1093/femspd/ftv022. Epub 2015 Apr 9. Pathog Dis. 2015. PMID: 25862675
Here we evaluated the ability of protein F to modulate the frequency of CD4+CD25+FoxP3+T and IL-10+T cells in patients with chronic HCV infection. F gene was amplified and cloned in the expression vector. The protein was purified and used for stimulation of PBMCs in …
Here we evaluated the ability of protein F to modulate the frequency of CD4+CD25+FoxP3+T and IL-10+T cells in patients with ch …
122 results